Development of a Sensitive Assay to Screen Nanoparticles in vitro for Complement Activation
2020
Nanomedicines are often recognized by the innate immune system as a threat, leading to unwanted clearance due to complement activation. This adverse reaction not only alters the bioavailability of ...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
85
References
3
Citations
NaN
KQI